Age and Gender: Affecting the Positive Rates of Serum PAB and ANCA in Patients with Inflammatory Bowel Disease

Table 1

Positive rate of ASCA, GAB, PAB, and ANCA in patients with IBD.

Antibodies	No. (%)			value
	Total ()	Female ()	Male ()
ASCA IgG	149 (7.96)	71 (9.38)	78 (7.00)	0.062
ASCA IgA	174 (9.30)	65 (8.59)	109 (9.78)	0.381
GAB IgG	642(34.31)	249 (32.89)	393 (35.28)	0.286
GAB IgA	48 (2.57)	21 (2.77)	27 (2.42)	0.638
PAB IgG	244 (13.04)	74 (9.78)	170 (15.26)	<0.001
PAB IgA	97 (5.18)	39 (5.15)	58 (5.21)	0.958
ANCA IgG	155 (8.28)	82 (10.83)	73 (6.55)	<0.001
ANCA IgA	96 (5.13)	55 (7.27)	41 (3.68)	<0.001

Data were presented as No. (percentage) and calculated by using test. ASCA: anti-Saccharomyces cerevisiae antibodies; GAB: anti-intestinal goblet cell antibodies; PAB: antibodies to exocrine pancreas; ANCA: anti-neutrophil cytoplasmic antibodies; IBD: inflammatory bowel disease. values indicate differences between female and male patients with IBD. was considered statistically significant.